agilon health inc. (AGL) vs Mangoceuticals (MGRX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
agilon health inc. is the larger company by market cap ($1.40 billion vs $9.4 million), about 149.6 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | AGL | MGRX |
|---|---|---|
| Share price | $83.63 | $0.4351 |
| Market cap | $1.40B | $9.38M |
| 1-day change | -2.42% | -1.91% |
| YTD return | +397.53% | — |
| 1-year return | +223.40% | — |
| 5-year return | -85.69% | — |
| Forward P/E | 35.41 | — |
| EPS (TTM) | $-15.41 | $-1.02 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $133.04 | $2.75 |
| 52-week low | $7.48 | $0.162 |
| Distance from 52-week high | -37.14% | -84.18% |
| Analyst consensus | buy | — |
| Avg. price target upside | +38.50% | — |
| Average volume | 291.69K | 12.83M |
| Shares outstanding | 16.79M | 21.57M |
| Employees | 856 | — |
| Sector | Health Care | Health Care |
| Industry | Misc Health and Biotechnology Services | Misc Health and Biotechnology Services |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- agilon health inc. is about 149.6 times larger than Mangoceuticals by market value ($1.40B vs $9.38M).
About agilon health inc.
AGL stock →agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States.
Health Care · Misc Health and Biotechnology Services · 856 employees
AGL vs MGRX FAQ
Which is bigger, agilon health inc. or Mangoceuticals?
agilon health inc. (AGL) is larger, with a market capitalization of $1.40B compared with $9.38M for Mangoceuticals (MGRX).
Are agilon health inc. and Mangoceuticals in the same industry?
Yes. Both are classified in the Misc Health and Biotechnology Services industry within the Health Care sector.